This class is recorded and distributed after event to all who sign up
Irritable Bowel Syndrome (IBS) is one of the most common gastrointestinal conditions, affecting up to 15% of the population. Treatment for IBS has largely been focused on addressing symptoms, but recent advances in research and methodology hold promise for improved assessment and treatment approaches.
These advancements include important new insights into the roles of immune activation, mast cells, microbiome imbalances, and microbial products such as histamine, serotonin, LPS, gases, and more.
In this class, practitioners will learn how advanced gastrointestinal health testing with GI-MAP can provide practitioners with important new clinical insights that facilitate improved personalization and targeting of treatment for patients with IBS.
5 LEARNING POINTS
Understand how certain food components can lead to increased immune reactivity and mast cell activation, which in turn, can promote symptoms such as bloating, abdominal pain, and motility disturbances in patients with IBS
Learn how gut microbes and their products can lead to increased immune reactivity and activation of mast cells
Understand how specific upstream imbalances can promote downstream imbalances within the gastrointestinal tract
Identify the most common GI-MAP dysbiosis patterns observed in IBS patients
Relate specific microbial imbalances to disturbances in digestive and immune markers
Understand how GI-MAP results can inform your treatment plan for your IBS patients
This free course is hosted by Rupa Health — the best way to order, track, and get results from 30+ lab companies in one place.
Rupa reduces the time spent ordering labs by 90% and provides customer service for your patients around lab test collections.